# Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/regorafenib-efficacy-after-sorafenib-in-patients-with-recurrent-hepatocellular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Massimo Iavarone,Federica Invernizzi,Tommy Ivanics,Stefano Mazza,Claudio Zavaglia,Marco Sanduzzi‐Zamparelli,Miguel Fraile‐López,Carolin Czauderna,Giovanni Di Costanzo,Sherrie Bhoori,Matthias Pinter,M.A. Manini,Giuliana Amaddeo,Ainhoa Fernández Yunquera,Federico Piñero,María José Blanco Rodríguez,Margarita Anders,Gabriel Aballay Soteras,Gerda Elisabeth Villadsen,Peter Yoon,Lucia Cesarini,Álvaro Díaz‐González,M.L. González-Diéguez,Raffaella Tortora,Arndt Weinmann,Vincenzo Mazzaferro,Mario Romero Cristóbal,Gonzalo Crespo,Hélène Regnault,Massimo De Giorgio,Marı́a Varela,Rebecca M. Prince,Luigia Scudeller,Maria Francesca Donato,Marcus‐Alexander Wörns,Jordi Bruix,Gonzalo Sapisochín,Pietro Lampertico,María Reig |
| Citations | 36 |
| DOI | 10.1002/lt.26264 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3192211563 |
| PMID | 34388851 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Stefano Mazza](https://scholariq.org/researchers/stefano-mazza/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.